The U.S. Food and Drug Administration (U.S. FDA) has issued five observations, post inspection, to the manufacturing plant of Zydus in Moraiya, Ahmedabad.

The inspection was conducted from October 5-13 and closed with 5 observations. The company will closely work with the U.S. FDA to address the observations expeditiously, Zydus Lifesciences said on Tuesday.